The study drug GLPG1972 is an investigational tablet taken by mouth.
An “Investigational” drug is a medication that the US Food and Drug Administration (FDA) does not allow to be sold in the US for treating patients. The drug can only be used for research purposes.
The study drug is designed to inhibit a protein that plays a key role in cartilage destruction, which causes osteoarthritis. By blocking this protein, GLPG1972 could prevent or decrease cartilage destruction to treat osteoarthritis, specifically in the knee.
Yes, multiple healthy subjects have taken GLPG1972. The drug was well-tolerated. Different doses of the drug have also been tested in patients with osteoarthritis, and the drug was well-tolerated. The Roccella study will see how effective the determined dose of GLPG1972 is on osteoarthritis in the knee.
Answering a few questions can help determine if participating in the Roccella study may be an option for you. If you qualify, the information you provide will be sent to the study site nearest you.